Mast cells are now known to derive from CD34+ haemopoietic stem cells in the bone marrow. However, it has not yet been established whether the various types of mastocytosis, which involve tumour-like proliferation of mast cells, are true neoplastic disorders or reactive/hyperplastic conditions. In this study, tissue specimens (five bone marrow, two spleen, one skin) from female patients with histologically confirmed mastocytosis were investigated with a recently developed polymerase chain reaction assay for the determination of clonality of female cells using the human androgen receptor gene (HU-MARA). Mast cells purified to near homogeneity from hysterectomy specimens served as a control. The findings in bone marrow and skin either were not reproducible, or indicated polyclonality. However, both spleen specimens exhibited monoclonality. In addition, DNA analysis by flow cytometry was performed and revealed a diploid chromosome content with proliferation indices of under 8% in all the specimens. This is the first molecular biological study to indicate that mastocytosis is indeed neoplastic in nature. (3 Clin Pathol 1997;50:525-527) 
Mast cells originate from haemopoietic tissue in the bone marrow, and have now been shown to be derived specifically from CD34+ progenitor cells. 1 However, it has not been established whether the various types of mastocytosis are true neoplastic disorders or reactive/hyperplastic conditions. This study was undertaken to investigate this problem in tissue specimens from patients with histologically confirmed mastocytosis, using a recently developed assay for the analysis of clonality at the human androgen receptor (HUMARA) loCUS.2 3 Methods and results The HUMARA assay was performed on formalin fixed, paraffin wax embedded specimens of bone marrow (iliac crest biopsy speci- (fig 1 B) . Heterozygosity was demonstrated in the form of two bands in the undigested DNA preparations from both these specimens. The control specimens (spleen and native uterine mast cells) exhibited polyclonality.
Flow cytometry revealed a diploid nuclear DNA content and a proliferation index of less than 8% in both the normal mast cells and those obtained from the splenic tissue from mastocytosis cases.
Discussion
This study was undertaken to investigate the hypothesis that mastocytosis exhibits a monoclonal growth pattern. This was performed with an assay for non-random X chromosome inactivation at the first exon of the HUMARA gene." The PCR technique used involves analysis of naturally occurring allelic polymorphism. This polymorphism is reflected in the presence or absence of cleavage sites for a particular restriction endonuclease (restriction fragment length polymorphism; RFLP). The loss of genetic material can be identified by reduced intensity of the PCR products of one of the two corresponding alleles in the tumour DNA. The HUMARA assay for clonality uses PCR to determine the relative proportions of maternal and paternal inactive X chromosomes. Therefore, this method can be used to identify monoclonal cell proliferation in females. Each member of a monoclonal cell population in a female contains the same (nonrandom) copy of the inactivated X chromosome, unlike those of the surrounding polyclonal tissues, which possess, on average, equal (random) numbers of paternal and maternal inactive X chromosomes. The first exon of the HUMARA locus contains two cleavage sites each for HpaII and HhaI upstream from polymorphic trinucleotide repeats. Methylation of these cleavage sites correlates with X chromosome inactivation.2" Primers are prepared that flank both the methylation sensitive cleavage sites and the trinucleotide repeats. Digestion with methylation sensitive restriction enzymes followed by PCR of the polymorphic region produces a single band, in the case of monoclonality, and two bands, in the case of polyclonality. The HUMARA assay has proved to be a sensitive method for determination of the clonality of various tumours and tumour precursor cells.' 6 7 Other authors have also shown that this method can be used on formalin fixed, paraffin embedded material because fixation with formalin does not interfere with DNA methylation.8 The great advantages of analysis of clonality at the HUMARA locus lie in its high degree of allelic variability (informativeness > 90%) both in the form of a variable number of trinucleotide repeats, and the proximity of the differentially methylated restriction sites to these repeats. These are necessary criteria for the analysis of clonality. 6 The HUMARA assay revealed monoclonality in both spleen samples from cases of malignant mastocytosis without an associated myeloproliferative/myelodysplastic syndrome. Monoclonality could not be demonstrated in any of the other mastocytosis specimens or P...& s.-W ., >l-controls. To the best of our knowledge, this is the first investigation in which monoclonality in mastocytosis has been demonstrated directly by a molecular biological technique. Our findings are consistent with those of two recently published studies, in which point mutations of the proto-oncogene c-kit were found in peripheral blood cells9 and mast cells of both skin and spleen'0 in mastocytosis. Additional DNA analysis by flow cytometry revealed no quantitative DNA abnormality severe enough to be detectable. The proliferation index of less than 8% indicates that malignant mastocytosis is a relatively slow growing tumour, compatible with the finding that, in this disease, the extent of mast cell infiltration often remains stable in serial biopsies.
No definite conclusions can be drawn about the biological nature of the mastocytoses from this study because of the small number of cases included and the fact that it may vary among the various different subtypes of mastocytosis. Further molecular biological investigations on defined subtypes are therefore planned. 
